Loading...

FDA Approval And Cell Therapies Will Transform DMD Patient Care

Published
26 Aug 25
Views
57
n/a
n/a
AnalystHighTarget's Fair Value
n/a
Loading
1Y
108.9%
7D
-8.8%

Author's Valuation

US$299.8% undervalued intrinsic discount

AnalystHighTarget Fair Value